SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-008778
Filing Date
2024-01-31
Accepted
2024-01-31 16:01:44
Documents
2
Group Members
ARUN KUMAR PILLAI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm244744d1_sc13da.htm SC 13D/A 80543
2 EXHIBIT 1 tm244744d1_ex-1.htm EX-99.1 5736
  Complete submission text file 0001104659-24-008778.txt   88240
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89495 | Film No.: 24582802
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877
Business Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877 962 6 582 7999
Tenshi Healthcare Pte. Ltd. (Filed by) CIK: 0001716335 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A